Covid-19: Hospitals can remove 15% cap on testing of NHS staffBMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1339 (Published 01 April 2020) Cite this as: BMJ 2020;369:m1339
NHS hospitals have been told to remove the 15% cap on the proportion of tests for covid-19 infection that they allocate to staff, as the government strives to get more staff who are currently isolating back to work as quickly as possible.
The move comes as the UK government faces mounting criticism over its inability to ramp up testing capacity quickly enough. As of 1 April the government said that there was capacity for testing 12 750 people a day—a fraction of the number being tested in other countries, such as Germany, which is testing around 70 000 people a day.
On Friday the UK government announced that it was opening three new labs specifically to process tests from NHS staff,1 but capacity is very limited, and medical leaders are frustrated by the lack of progress.
Chaand Nagpaul, BMA council chair, said, “It’s been weeks since the government said they would make priority testing for healthcare workers happen, so the profession deserves this to become a reality now.”
On 29 March NHS England bosses wrote to all NHS trusts,2 asking them to consider how they would prioritise staff for testing and advising them to start with those working in critical care, emergency departments, and ambulance services. Trusts were asked to allocate a maximum of 15% of their daily testing capacity to this purpose.
But on 1 April NHS England wrote to hospitals to say that the cap was being removed as capacity increased.3 The letter said, “We want to max-out all available capacity . . . and so are now removing the 15% cap immediately. Effective today we are therefore asking chief executives of trusts that host an NHS lab doing covid-19 testing personally to ensure that your lab’s capacity is fully used each and every day.”
Chris Hopson, chief executive of NHS Providers, which represents NHS trusts, said that he had seen preliminary data from staff who had been tested for covid-19 that suggested only a small proportion had the virus. This, he said, highlighted the importance of rolling out staff testing more widely.
He wrote on Twitter,4 “Intriguing data from a very small sample size . . . only around 15% of those in 14 day isolation tested positive so other 85% could come back to work. If [this is] anything like right, a huge opportunity.”
On 31 March the cabinet office minister Michael Gove said that a global shortage of reagent chemicals was holding back efforts to ramp up capacity in the UK.
Hopson commented that trust leaders were reporting “major shortages of swabs and chemicals needed to complete tests” but that logistics were also an issue, with “some labs not working at full capacity [and] others struggling with high volumes.”
With the UK lagging way behind many other countries on testing, the UK’s strategy of centralising covid-19 testing in a single large warehouse near Milton Keynes is among various policy decisions that are under scrutiny.
Quizzed on BBC Radio 4’s Today programme on 1 April5 as to why extra laboratory capacity in universities and in the private sector was not being used, the communities secretary, Robert Jenrick, insisted that the government was open to offers. “We want to work with any provider who can help us to ramp up production,” he said.
Jenrick added that he expected the UK’s overall testing capacity to reach 25 000 “by the middle of April.”
This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage